Estimaciones de analistas de Wall Street para Inotiv, Inc. (NOTV): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-08-05 | $-0.47 | ||
| 2026-05-11 | $-0.94 | $-0.64 | -48.0% |
| 2026-02-09 | $-0.72 | $-0.64 | -12.9% |
| 2025-12-03 | $-0.14 | $-0.46 | +69.6% |
| 2025-08-06 | $-0.12 | $-0.15 | +20.0% |
| 2025-05-07 | $-0.18 | $-0.24 | +25.0% |
| 2025-02-05 | $-0.42 | $-0.42 | +0.0% |
| 2024-12-03 | $-0.16 | $-0.91 | +82.4% |
Ratios de valoración
| Precio / Valor contable | 0.04 |
| EV / EBITDA | 46.61 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $20.4M | $24.2M | $26.3M | $43.6M | $60.5M | $89.6M | $547.7M | $572.4M | $490.7M | $513.0M |
| Coste de Ventas | $16.0M | $16.5M | $18.2M | $30.7M | $42.2M | $59.4M | $390.4M | $407.0M | $379.6M | $448.0M |
| Beneficio Bruto | $4.4M | $7.7M | $8.1M | $12.9M | $18.2M | $30.2M | $157.2M | $165.4M | $111.2M | $65.1M |
| I+D | $496000 | $465000 | $596000 | $627000 | $950000 | $405000 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $6.0M | $6.0M | $7.5M | $12.4M | $20.4M | $33.9M | $99.1M | $127.3M | $97.9M | $92.2M |
| Gastos Operativos | $6.5M | $6.4M | $8.1M | $13.1M | $21.3M | $35.8M | $184.7M | $246.9M | $197.6M | $96.0M |
| Beneficio Operativo | -$3.0M | $1.3M | $14000 | -$153000 | -$3.1M | $1.5M | -$27.4M | -$81.5M | -$86.4M | -$30.9M |
| EBITDA | -$1.3M | $3.0M | $1.9M | $2.6M | $1.0M | $15.4M | -$273.4M | -$26.5M | -$26.8M | $24.8M |
| Gastos por Intereses | $399000 | $375000 | $274000 | $642000 | $1.5M | $1.7M | $29.7M | $43.0M | $46.9M | $56.6M |
| Beneficio Antes de Impuestos | -$3.2M | $908000 | -$254000 | -$786000 | -$4.5M | $6.1M | -$352.4M | -$124.2M | -$130.8M | -$87.8M |
| Impuestos | -$14000 | $24000 | -$60000 | $4000 | $147000 | -$4.8M | -$15.2M | -$19.3M | -$21.9M | -$19.1M |
| Beneficio Neto | -$3.2M | $884000 | -$194000 | -$790000 | -$4.7M | $10.9M | -$337.3M | -$105.1M | -$108.4M | -$68.6M |
| BPA | $-0.40 | $0.11 | $-0.02 | $-0.08 | $-0.43 | $0.83 | $-13.85 | $-4.10 | $-4.19 | $-2.11 |
| BPA Diluido | $-0.40 | $0.10 | $-0.02 | $-0.08 | $-0.43 | $0.79 | $-13.85 | $-4.10 | $-4.19 | $-2.11 |
| Acciones en Circulación (Diluidas) | $8.1M | $8.7M | $8.8M | $10.4M | $10.9M | $13.9M | $24.4M | $25.6M | $25.9M | $32.5M |
Precio
| Precio | $0.08 |
| Capitalización | $3M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BDSX · BEAT · BIAF · CELU · FGEN · KZR · QNTM
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de NOTV: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones